Published in N Engl J Med on February 16, 2012
Platelets increase the proliferation of ovarian cancer cells. Blood (2012) 1.97
The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. Nat Rev Drug Discov (2013) 1.93
Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol (2015) 1.65
Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma. JAMA Oncol (2015) 1.49
Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol (2012) 1.48
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. J Clin Invest (2016) 1.45
Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers. AIDS (2013) 1.34
Platelets guide the formation of early metastatic niches. Proc Natl Acad Sci U S A (2014) 1.24
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer. Mol Syst Biol (2014) 1.21
Trial Watch: Immunostimulatory cytokines. Oncoimmunology (2012) 1.19
The risk of oesophago-gastric cancer in symptomatic patients in primary care: a large case-control study using electronic records. Br J Cancer (2012) 1.18
Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells. Cancer Discov (2012) 1.16
Platelets at the interface of thrombosis, inflammation, and cancer. Blood (2015) 1.11
Hematogenous metastasis of ovarian cancer: rethinking mode of spread. Cancer Cell (2014) 1.09
Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev (2014) 1.07
Risk of uterine cancer in symptomatic women in primary care: case-control study using electronic records. Br J Gen Pract (2013) 1.05
Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients. J Gastrointest Cancer (2013) 1.03
Paraneoplastic thrombocytosis: the secrets of tumor self-promotion. Blood (2014) 1.02
The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nat Med (2014) 1.01
Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer. Gynecol Oncol (2013) 0.99
Sleep disturbance, cytokines, and fatigue in women with ovarian cancer. Brain Behav Immun (2012) 0.97
Thrombocytosis and hepatocellular carcinoma. Dig Dis Sci (2013) 0.94
Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro. BMC Cancer (2014) 0.94
Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients. Tumour Biol (2016) 0.93
Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival. Br J Cancer (2015) 0.92
A preoperative personalized risk assessment calculator for elderly ovarian cancer patients undergoing primary cytoreductive surgery. Gynecol Oncol (2015) 0.90
VEGF levels and the angiogenic potential of the microenvironment can affect surgical strategy for colorectal liver metastasis. Cell Adh Migr (2012) 0.90
Interleukin-6 Stimulates Defective Angiogenesis. Cancer Res (2015) 0.90
The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study. Haematologica (2014) 0.90
Differential platelet levels affect response to taxane-based therapy in ovarian cancer. Clin Cancer Res (2014) 0.89
CLEC-2 in megakaryocytes is critical for maintenance of hematopoietic stem cells in the bone marrow. J Exp Med (2015) 0.89
The prothrombotic activity of cancer cells in the circulation. Blood Rev (2015) 0.88
Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer (2015) 0.87
P-Selectin-Mediated Adhesion between Platelets and Tumor Cells Promotes Intestinal Tumorigenesis in Apc(Min/+) Mice. Int J Biol Sci (2015) 0.86
New developments in the treatment of ovarian cancer--future perspectives. Ann Oncol (2013) 0.86
Venous thrombosis and cancer: from mouse models to clinical trials. J Thromb Haemost (2015) 0.86
Retracted Targeted immune therapy of ovarian cancer. Cancer Metastasis Rev (2015) 0.84
Pretreatment thrombocytosis as a prognostic factor in metastatic breast cancer. Int J Breast Cancer (2013) 0.84
Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancer. Proc Natl Acad Sci U S A (2015) 0.84
Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines. BMC Cancer (2014) 0.83
Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer. Clin Cancer Res (2015) 0.83
Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer. World J Surg Oncol (2014) 0.83
Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status. World J Exp Med (2014) 0.83
Regulating billions of blood platelets: glycans and beyond. Blood (2015) 0.83
Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis. Sci Rep (2016) 0.82
Platelet effects on ovarian cancer. Semin Oncol (2014) 0.82
Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer. Cancer Res (2015) 0.82
Living in shear: platelets protect cancer cells from shear induced damage. Clin Exp Metastasis (2014) 0.82
Prognostic value of hematological parameters in patients undergoing esophagectomy for esophageal squamous cell carcinoma. Int J Clin Oncol (2016) 0.82
Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer. Gynecol Oncol (2015) 0.81
Role of ADP receptors on platelets in the growth of ovarian cancer. Blood (2017) 0.81
Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study. Gastric Cancer (2015) 0.81
Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1. J Exp Clin Cancer Res (2015) 0.81
STAMP2 increases oxidative stress and is critical for prostate cancer. EMBO Mol Med (2015) 0.81
Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism. Mol Med Rep (2014) 0.80
Assessment of Multiplate platelet aggregometry using citrate, heparin or hirudin in Rhesus macaques. Platelets (2014) 0.80
Thrombocytosis portends adverse prognostic significance in patients with stage II colorectal carcinoma. F1000Res (2014) 0.80
Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations. Int J Cell Biol (2016) 0.79
Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients. BMC Cancer (2016) 0.79
Expression of angiogenesis regulatory proteins and epithelial-mesenchymal transition factors in platelets of the breast cancer patients. ScientificWorldJournal (2014) 0.79
Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer. PLoS One (2015) 0.79
The role of interleukin-6 in malignant mesothelioma. Transl Lung Cancer Res (2015) 0.78
Prognostic significance of preoperative platelet count in patients with gallbladder cancer. World J Gastroenterol (2015) 0.78
Platelets are not hyperreactive in patients with ovarian cancer. Platelets (2016) 0.78
Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal. Immunol Rev (2016) 0.78
Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer. Obstet Gynecol Sci (2014) 0.78
Presence of intratumoral platelets is associated with tumor vessel structure and metastasis. BMC Cancer (2014) 0.77
Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor. Cancer Chemother Pharmacol (2015) 0.77
Preoperative thrombocytosis predicts prognosis in stage II colorectal cancer patients. Ann Surg Treat Res (2016) 0.76
Prognostic factors for overall survival in metastatic colorectal cancer using a stop-and-go FLIRI-based treatment strategy. Int J Colorectal Dis (2015) 0.76
Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma. Gynecol Oncol (2015) 0.76
Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte. Medicine (Baltimore) (2016) 0.76
Siltuximab (CNTO 328): a promising option for human malignancies. Drug Des Devel Ther (2015) 0.76
Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation. Int J Cancer (2015) 0.75
Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy. BMC Surg (2016) 0.75
Curiositas (General Practice). Ulster Med J (2017) 0.75
Immuno-stimultory/regulatory gene expression patterns in advanced ovarian cancer. Genes Cancer (2015) 0.75
Novel mechanisms of platelet clearance and thrombopoietin regulation. Curr Opin Hematol (2015) 0.75
A prospective comparative clinical study of peripheral blood counts and indices in patients with primary brain tumors. J Postgrad Med (2016) 0.75
Lipid profile of platelets and platelet-derived microparticles in ovarian cancer. BBA Clin (2016) 0.75
Novel Inflammation-Based Prognostic Score for Predicting Survival in Patients with Metastatic Urothelial Carcinoma. PLoS One (2017) 0.75
Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer. Invest New Drugs (2015) 0.75
Utility of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios to distinguish malignant from benign ovarian masses. J Turk Ger Gynecol Assoc (2016) 0.75
Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med (2012) 0.75
Circulating blood and platelets supply glycosyltransferases that enable extrinsic extracellular glycosylation. Glycobiology (2016) 0.75
Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records. BMC Cancer (2016) 0.75
Chemotherapy Response Rates Among Patients With Endometrial Cancer Who Have Elevated Serum Platelets. Int J Gynecol Cancer (2015) 0.75
Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer. Mol Cancer Ther (2016) 0.75
Lack of association between platelet indices and disease stage in osteosarcoma at diagnosis. PLoS One (2017) 0.75
Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer. Gynecol Oncol (2017) 0.75
Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinoma. Ecancermedicalscience (2012) 0.75
A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets. Platelets (2016) 0.75
Thrombopoietin Secretion by Human Ovarian Cancer Cells. Int J Cell Biol (2017) 0.75
Defining optimal cut-off values and research methodology for evaluating systemic inflammatory markers in clinical outcome prediction. World J Surg (2012) 0.75
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation. Sci Rep (2017) 0.75
Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma. World J Gastrointest Oncol (2017) 0.75
Platelet clearance by the hepatic Ashwell-Morrell receptor: mechanisms and biological significance. Thromb Res (2016) 0.75
Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes. J Clin Invest (2017) 0.75
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 11.00
Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med (2008) 8.77
Aspirin use and survival after diagnosis of colorectal cancer. JAMA (2009) 6.93
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med (2006) 6.18
Lineage-specific hematopoietic growth factors. N Engl J Med (2006) 3.73
Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res (2006) 3.58
Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat Protoc (2009) 3.36
Regulation of tumor angiogenesis by EZH2. Cancer Cell (2010) 3.10
Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res (2011) 2.85
Platelet alpha-granules: basic biology and clinical correlates. Blood Rev (2009) 2.72
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood (2001) 2.40
THROMBOCYTOSIS ASSOCIATED WITH MALIGNANT DISEASE. Arch Intern Med (1964) 2.26
Cell biology. Beyond clotting: the powers of platelets. Science (2010) 1.64
Clinical and biological significance of vascular endothelial growth factor in endometrial cancer. Clin Cancer Res (2007) 1.51
Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor. J Immunol (2010) 1.39
The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther (2008) 1.38
Thrombopoietin. N Engl J Med (1998) 1.32
Dual targeting of EphA2 and FAK in ovarian carcinoma. Cancer Biol Ther (2009) 1.30
Impact of vessel maturation on antiangiogenic therapy in ovarian cancer. Am J Obstet Gynecol (2008) 1.25
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation. Cochrane Database Syst Rev (2007) 1.20
Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease. Cancer Res (2005) 1.20
Platelets: guardians of tumor vasculature. Cancer Res (2009) 1.11
Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer. Clin Cancer Res (2005) 1.10
Thrombopoietin production in wild-type and interleukin-6 knockout mice with acute inflammation. J Interferon Cytokine Res (2005) 0.98
Megakaryocyte quantifications in relation to thrombokinetics in primary thrombocythaemia and allied diseases. Scand J Haematol (1975) 0.93
Cancer-related inflammation. Nature (2008) 34.21
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res (2012) 13.14
Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med (2007) 12.55
Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med (2008) 8.77
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol (2003) 8.31
H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science (2008) 7.89
The Genomes of Oryza sativa: a history of duplications. PLoS Biol (2005) 7.67
Electric-field control of local ferromagnetism using a magnetoelectric multiferroic. Nat Mater (2008) 7.23
Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA (2011) 6.81
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med (2006) 6.18
MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol (2011) 5.46
Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer (2011) 5.28
Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206. J Clin Oncol (2005) 4.77
H2S signals through protein S-sulfhydration. Sci Signal (2009) 4.54
Outcome of the first electron microscopy validation task force meeting. Structure (2012) 4.35
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer (2006) 4.27
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res (2005) 4.24
Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nat Genet (2013) 3.96
Extended high viremics: a substantial fraction of individuals maintain high plasma viral RNA levels after acute HIV-1 subtype C infection. AIDS (2011) 3.95
Spread of a novel influenza A (H1N1) virus via global airline transportation. N Engl J Med (2009) 3.80
Structure of epsilon15 bacteriophage reveals genome organization and DNA packaging/injection apparatus. Nature (2006) 3.73
Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol (2008) 3.68
Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res (2006) 3.58
Backbone structure of the infectious epsilon15 virus capsid revealed by electron cryomicroscopy. Nature (2008) 3.54
Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol (2004) 3.49
RNA interference in the clinic: challenges and future directions. Nat Rev Cancer (2010) 3.43
Latent TGF-β structure and activation. Nature (2011) 3.42
De novo backbone trace of GroEL from single particle electron cryomicroscopy. Structure (2008) 3.41
The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res (2010) 3.36
EMDataBank.org: unified data resource for CryoEM. Nucleic Acids Res (2010) 3.32
Close membrane-membrane proximity induced by Ca(2+)-dependent multivalent binding of synaptotagmin-1 to phospholipids. Nat Struct Mol Biol (2006) 3.14
Identification of targetable FGFR gene fusions in diverse cancers. Cancer Discov (2013) 3.13
Protein structure fitting and refinement guided by cryo-EM density. Structure (2008) 3.12
Regulation of tumor angiogenesis by EZH2. Cancer Cell (2010) 3.10
Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe (2010) 3.08
VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell (2012) 3.01
Refinement of protein structures into low-resolution density maps using rosetta. J Mol Biol (2009) 2.94
Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res (2011) 2.94
Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol (2011) 2.90
H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol (2002) 2.90
The structure of ClpB: a molecular chaperone that rescues proteins from an aggregated state. Cell (2003) 2.89
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res (2006) 2.86
Mechanism of folding chamber closure in a group II chaperonin. Nature (2010) 2.85
Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res (2011) 2.85
Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res (2010) 2.80
Coat protein fold and maturation transition of bacteriophage P22 seen at subnanometer resolutions. Nat Struct Biol (2003) 2.76
Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev (2005) 2.73
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat Mater (2011) 2.71
The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res (2007) 2.71
Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A (2009) 2.66
Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol (2004) 2.62
Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy (2010) 2.62
Complete transfer of perceptual learning across retinal locations enabled by double training. Curr Biol (2008) 2.62
Common ancestry of herpesviruses and tailed DNA bacteriophages. J Virol (2005) 2.60
Identification of secondary structure elements in intermediate-resolution density maps. Structure (2007) 2.60
Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol (2012) 2.56
Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells. J Am Chem Soc (2008) 2.56
GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci U S A (2009) 2.51
Seeing GroEL at 6 A resolution by single particle electron cryomicroscopy. Structure (2004) 2.50
Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res (2003) 2.50
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother (2012) 2.49
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res (2005) 2.48
Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. Cancer (2003) 2.48
Quantitative analysis of cryo-EM density map segmentation by watershed and scale-space filtering, and fitting of structures by alignment to regions. J Struct Biol (2010) 2.48
The role of the fallopian tube in the origin of ovarian cancer. Am J Obstet Gynecol (2013) 2.47
Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One (2010) 2.44